(Q43807588)

27 November 2017

title

Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site (English)

1 reference

27 November 2017

1 reference

Weatherman RV

1

1 reference

27 November 2017

Carroll DC

series ordinal

2

1 reference

27 November 2017

Scanlan TS

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

published in

1 reference

27 November 2017

volume

11

1 reference

27 November 2017

issue

24

1 reference

27 November 2017

page(s)

3129-3131

1 reference

Nuclear-receptor ligands and ligand-binding domains

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Therapeutic potential of selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Molecular determinants of tissue selectivity in estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for bone over uterus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900646-1

7 January 2021

10.1016/S0960-894X(01)00646-1

Identifiers

DOI

1 reference

27 November 2017

1 reference